(Q46973688)

27 December 2017

title

Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study (English)

1 reference

27 December 2017

0 references

5

Christer Halldin

1 reference

27 December 2017

6

Lars Farde

1 reference

27 December 2017

author name string

Aurelija Jucaite

1

1 reference

27 December 2017

Ikuo Odano

2

1 reference

27 December 2017

Hans Olsson

3

1 reference

27 December 2017

Stefan Pauli

4

1 reference

27 December 2017

publication date

3 March 2006

1 reference

27 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

27 December 2017

volume

33

1 reference

27 December 2017

issue

6

1 reference

27 December 2017

page(s)

657-668

1 reference

27 December 2017

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Strategies for in vivo measurement of receptor binding using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-0027-9

Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.

21 January 2018

1 reference

12 December 2020

Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.

1 reference

12 December 2020

Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I.

1 reference

12 December 2020

Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.

1 reference

12 December 2020

Immunocytochemical localization of the dopamine transporter in human brain

1 reference

12 December 2020

Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain

1 reference

12 December 2020

Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter

1 reference

12 December 2020

[18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter

1 reference

12 December 2020

Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man

1 reference

12 December 2020

The ECAT EXACT HR: performance of a new high resolution positron scanner.

1 reference

12 December 2020

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

1 reference

12 December 2020

Quantification of [(123)I]PE2I binding to dopamine transporters with SPET.

1 reference

12 December 2020

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity

1 reference

12 December 2020

Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.

1 reference

12 December 2020

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain

1 reference

12 December 2020

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

12 December 2020

Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease

1 reference

12 December 2020

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective co

1 reference

12 December 2020

Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI

1 reference

12 December 2020

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

12 December 2020

Comparison of methods for analysis of clinical [11C]raclopride studies.

1 reference

12 December 2020

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

1 reference

12 December 2020

Simplified reference tissue model for PET receptor studies.

1 reference

12 December 2020

Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography

1 reference

12 December 2020

Positron emission tomography: imaging and quantification of neurotransporter availability

1 reference

12 December 2020

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

1 reference

12 December 2020

[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain

1 reference

12 December 2020

Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa

1 reference

12 December 2020

Brain radioligands--state of the art and new trends

1 reference

12 December 2020

Effects of statistical noise on graphic analysis of PET neuroreceptor studies.

1 reference

12 December 2020

Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man

1 reference

12 December 2020

The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT.

1 reference

12 December 2020

Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.

1 reference

12 December 2020

Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches

1 reference

12 December 2020

10.1007/S00259-005-0027-9

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017